Slides
Page 1
Q3 FY2026 Investor Presentation 8.5.2026 CENTRAL GARDEN & PET PENNINGTON ™ Cadet KAYTEE Nylabone CHEWS BEST CS . Made in the USA WILD BIRO SPECIALTY PRODUCTS AMDRO FARNAM AQUEON it's all about the fish . ZOËCON Professional Products SINCE 1856 FERRY - MORSE BEST BULLY STICKS GARDEN TECH . SEVIN
Page 2
2Q3 FY26 Investor Presentation Q3 Highlights & Outlook Niko Lahanas, CEO Management Q&A Niko Lahanas, Brad Smith, J.D. Walker, Jason Barnes, John Hanson Financials & Segments Brad Smith, CFO
Page 3
Forward-looking Statements The statements contained in this presentation which are not historical facts, including statements concerning productivity initiatives and earnings guidance for fiscal 2026, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from the forward-looking statements contained in this presentation. The range of risk factors is described in Central's filings with the SEC. Central undertakes no obligation to publicly update these forward- looking statements to reflect new information, subsequent events or otherwise, except as required by law. This presentation contains certain non-GAAP financial measures. For a reconciliation of GAAP to non-GAAP financial measures, please see the Reconciliation tables in the Appendix of this presentation or in Central's most recent Form 10-K and Form 10-Q. 3Q3 FY26 Investor Presentation
Page 4
4 Niko Lahanas CEO Q3 FY26 Investor Presentation
Page 5
5 Q3 FY26 Investor Presentation Solid FY26 Q3 Performance Non-GAAP Gross Margin up 140 bps Organic Sales up 2%
Page 6
6 6 Q3 FY26 Investor Presentation • Consolidated separate business-unit Garden logistics networks into one unified four-node national network, closing 13 facilities & opening two • ~95% complete: most projects on schedule, all under budget, minimal customer disruption • 1M+ small-parcel packages shipped since launch; rising utilization is lifting productivity, service levels, and customer responsiveness • Reflects Central's focus on disciplined execution, easier operations, and high-return capital allocation Project Horizon
Page 7
7 Acquisition of TRIXIE Q3 FY26 Investor Presentation • Europe's leading pet supplies and snacks company • TRIXIE serves 30,000+ retail stores globally, ~90% branded portfolio, strong innovation • Creates a leading global pet supplies platform with ~10% of sales outside the U.S. • Positioned for European market consolidation • Funded by Central's strong balance sheet; closing 1H FY27 • TRIXIE leadership retains minority stake and continues running the business • Meaningfully enhances Central's long-term growth outlook
Page 8
8 Q3 FY26 Investor Presentation Recent Innovation Continue to Perform Well ▪ Nylabone dog chew toys made with real meat ▪ Farnam’s Endure Gold Killer Fly & Mosquito Control Spray for horses ▪ The Rebel Sun & Shade extension in Grass Seed ▪ Newly awarded private label programs in Grass Seed and Fertilizer
Page 9
9Q3 FY26 Investor Presentation Risk & Market Considerations • Macroeconomic environment remains dynamic • Consumers continue to seek value and performance Raising Fiscal 2026 Outlook Raising non-GAAP EPS guidance from $2.70 or better to $2.85 or better
Page 10
10Q3 FY26 Investor Presentation Brad Smith CFO
Page 11
11Q3 FY26 Investor Presentation EPS (in $) Operating Income (in $ millions) Gross Margin (as a percentage of Net Sales) Net Sales (in $ millions) Solid FY26 Q3 Performance +130bps(8)% (0.07)(7)%
Page 12
12Q3 FY26 Investor Presentation Non-GAAP EPS (in $) Non-GAAP Operating Income (in $ millions) Non-GAAP Gross Margin (as a percentage of Net Sales) Organic Net Sales (in $ millions) Solid FY26 Q3 Performance - Non-GAAP +140bps+2% (2)% (0.02)
Page 13
13 1313 • Organic net sales: $380 million • Non-GAAP operating margin: 19.0% • Adjusted EBITDA: $86 million Results Q3 FY26 Investor Presentation FY26 Q3 Pet Segment Performance • Broad strength in the majority of our businesses • Online sales up 10% • Gained market share in Professional, Dog Treats, Rawhide, and Flea & Tick. T ailwinds & Successes
Page 14
14 14 • Net sales: $482 million • Non-GAAP Operating margin: 18.9% • Adjusted EBITDA: $101 million Q3 FY26 Investor Presentation Results FY26 Q3 Garden Segment Performance • Consumer demand strong across Fertilizer, Wild Bird, and Grass Seed • Strong eCommerce sales across all pure-play and omni-channel partners • Record sales in Fertilizer & Wild Bird • Market share gains led by Fertilizer, Wild Bird, and Grass Seed T ailwinds & Successes
Page 15
15Q3 FY26 Investor Presentation Share Repurchases (in $ millions) CapEx (in $ millions) Cash provided by Operations (in $ millions) Cash & Cash Equivalents (in $ millions) Improved Cash & Liquidity +$62+$284 $(54)($1.2)
Page 16
16Q3 FY26 Investor Presentation (1) Calculated as Indebtedness / Adj. EBITDA as defined by the Company's ABL credit agreement Strong Balance Sheet Positions for Additional M&A Gross Leverage Ratio(1) Long-T erm Debt (in $ millions) Borrowings on ABL Credit Facility
Page 17
Q3 FY26 Investor Presentation 17 Niko Lahanas CEO Brad Smith CFO John Hanson President, Pet Consumer Products JD Walker President, Garden Consumer Products Q&A Session Jason Barnes EVP , Garden Consumer Products
Page 18
18 Appendix
Page 19
19 We report our financial results in accordance with GAAP . However, to supplement the financial results prepared in accordance with GAAP , we use non-GAAP financial measures including non-GAAP net income and diluted net income per share, non-GAAP operating income, organic net sales and adjusted EBITDA. Management uses these non-GAAP financial measures that exclude the impact of specific items (described below) in making financial, operating and planning decisions and in evaluating our performance. Also, management believes that these non-GAAP financial measures may be useful to investors in their assessment of our ongoing operating performance and provide additional meaningful comparisons between current results and results in prior operating periods. While management believes that non-GAAP measures are useful supplemental information, such adjusted results are not intended to replace our GAAP financial results and should be read in conjunction with those GAAP results. We have also provided organic net sales, a non-GAAP measure that excludes the impact of businesses purchased or exited in the prior 12 months, because we believe it permits investors to better understand the performance of our historical business without the impact of recent acquisitions or dispositions. Adjusted EBITDA is defined by us as income before income tax, net other expense, net interest expense and depreciation and amortization and stock-based compensation expense (or operating income plus depreciation and amortization expense and stock-based compensation expense). Adjusted EBITDA further excludes charges related to facility closures. We present adjusted EBITDA because we believe that adjusted EBITDA is a useful supplemental measure in evaluating the cash flows and performance of our business and provides greater transparency into our results of operations. Adjusted EBITDA is used by our management to perform such evaluations. Adjusted EBITDA should not be considered in isolation or as a substitute for cash flow from operations, income from operations or other income statement measures prepared in accordance with GAAP . We believe that adjusted EBITDA is frequently used by investors, securities analysts and other interested parties in their evaluation of companies, many of which present adjusted EBITDA when reporting their results. Other companies may calculate adjusted EBITDA differently and it may not be comparable. Q3 FY26 Investor Presentation Use of Non-GAAP Financial Measures
Page 20
20 The reconciliations of these non-GAAP measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are shown in the tables below. Non-GAAP financial measures reflect adjustments based on the following items: • Facility closures and business exit: we have excluded charges related to the closure of distribution and manufacturing facilities and our decisions to exit businesses as they represent infrequent transactions that impact the comparability between operating periods. • Tariff refunds: we have excluded the impact of tariff refunds received for certain tariffs previously imposed under the International Emergency Economic Powers Act which were deemed unconstitutional. We believe the tariff refund amounts we have received represent infrequent transactions that impact the comparability between operating periods. • Business contribution to joint venture formation: we have excluded the gain related to the divestiture of the pet distribution business and its contribution to the formation of a joint venture as it represents an infrequent transaction that impacts the comparability between operating periods. Q3 FY26 Investor Presentation Use of Non-GAAP Financial Measures
Page 21
21 From time to time in the future, there may be other items that we may exclude if we believe that doing so is consistent with the goal of providing useful supplemental information to investors and management. 1. During the third quarter of fiscal 2026, we recognized incremental expense of $13.8 million in the consolidated statement of operations, of which $13.0 million in our Pet segment related to the exit of a minor business and the closure of two facilities, and $0.8million in our Garden segment related to the closure of three distribution centers in fiscal 2025 and 2024. 2. During the third quarter of fiscal 2026, we recognized incremental income in our Pet segment of $3.6 million for tariff refunds received. 3. During the third quarter of fiscal 2026, we recognized incremental income of $2.5 million in Other Income from the contribution of our pet distribution business to the formation of a new joint venture. 4. During the first six months of fiscal 2026, we recognized incremental expense of $8.0 million in the condensed consolidated statement of operations, of which $7.3 million in our Garden segment related to the closure of three distribution centers in fiscal 2025 and 2024 and $0.7 million in our Pet segment related to the closure of a sales and logistics facility in Pennsylvania. 5. During the third quarter of fiscal 2025, we recognized incremental expense of $3.9 million in the consolidated statement of operations, $2.2 million in our Garden segment related to closing a distribution facility in Ontario, California and beginning the consolidation of our Western distribution network and an incremental $1.7 million in our Pet segment related to the decision to winddown our operations in the U.K. 6. During the second quarter of fiscal 2025, we recognized incremental expense of $5.3 million in the condensed consolidated statement of operations, related to the decision to wind-down our operations in the U.K. and the related facility there as we move to a direct- export model. Q3 FY26 Investor Presentation Use of Non-GAAP Financial Measures
Page 22
22 GAAP to Non-GAAP Reconciliation for the Fiscal Quarter Ended (in thousands, except for per share amounts) Q3 FY26 Investor Presentation Net Income & Diluted Net Income Per Share Reconciliation June 27, 2026 June 28, 2025 GAAP net income attributable to Central Garden & Pet Company $ 89,856 $ 95,007 Facility closures (1) (4) (5) (6) 13,757 3,915 Tariff refunds (2) (3,606) — Pet distribution business divestiture (3) (2,479) — Tax effect of adjustments (1,900) (1,003) Non-GAAP net income attributable to Central Garden & Pet Company $ 95,628 $ 97,919 GAAP diluted net income per share $ 1.45 $ 1.52 Non-GAAP diluted net income per share $ 1.54 $ 1.56 Shares used in GAAP and non-GAAP diluted net earnings per share calculation 61,947 62,610
Page 23
23Q3 FY26Investor Presentation GAAP to Non-GAAP Reconciliation for the Fiscal Quarter Ended (in thousands) Operating Income Reconciliation June 27, 2026 GAAP Non-GAAP adjustments Non-GAAP Net sales $ 882,362 $ 1,354 $ 883,716 Cost of goods sold 565,444 129 565,573 Gross profit $ 316,918 $ 1,225 $ 318,143 Selling, general and administrative expenses 191,074 (8,926) 182,148 Income from operations (1) (2) (4) $ 125,844 $ 10,151 $ 135,995 Gross margin 35.9% 36.0% Operating margin 14.3% 15.4% Garden Segment Operating Income Reconciliation June 27, 2026 June 28, 2025 GAAP operating income $ 90,051 $ 82,989 Facility closures (1) (4) (5) 794 2,244 Non-GAAP operating income $ 90,845 $ 85,233 GAAP operating margin 18.7% 17.7% Non-GAAP operating margin 18.9% 18.2% Pet Segment Operating Income Reconciliation June 27, 2026 June 28, 2025 GAAP operating income $ 66,818 $ 76,199 Facility closures (1) (4) (5) (6) 12,963 1,671 Tariff refunds received (2) (3,606) — Non-GAAP operating income $ 76,175 $ 77,870 GAAP operating margin 16.7% 15.5% Non-GAAP operating margin 19.0% 15.8%
Page 24
24Q3 FY26 Investor Presentation Organic Net Sales Reconciliation Three Months Ended June 27, 2026 Net sales (GAAP) Effect of acquisitions & divestitures on net sales Net sales organic Q3 FY 26 $ 882.4 $ 20.2 $ 862.2 Q3 FY 25 960.9 118.7 842.2 $ increase (decrease) $ (78.5) $ 20.0 % increase (decrease) (8.2)% 2.4 % Organic Pet Segment Net Sales Reconciliation Three Months Ended June 27, 2026 Net sales (GAAP) Effect of acquisitions & divestitures on net sales Net sales organic Q3 FY 26 $ 400.5 $ 20.2 $ 380.3 Q3 FY 25 492.5 118.7 373.8 $ increase (decrease) $ (92.0) $ 6.5 % increase (decrease) (18.7)% 1.7 % GAAP to Non-GAAP Reconciliation for the Fiscal Quarter Ended (in millions)
Page 25
25 GAAP to Non-GAAP Reconciliation for the Fiscal Quarter Ended (in thousands) Adjusted EBITDA Reconciliation June 27, 2026 June 28, 2025 Net income attributable to Central Garden & Pet Company $ 89,856 $ 95,007 Interest expense, net 7,767 8,843 Other income (1,511) (1,069) Income tax expense 29,596 31,941 Net income attributable to noncontrolling interest 136 404 Income from operations $ 125,844 $ 135,126 Depreciation & amortization 19,634 21,483 Noncash stock-based compensation 6,245 6,044 Facility closures and business exits (Q3 26' is net of tariff refunds received) (1) (2) 10,151 (5) 3,915 Adjusted EBITDA $ 161,874 $ 166,568 Q3 FY26 Investor Presentation